The abstract is read at the publisher; the summary is JClub's.
Multimorbidity in COPD—coexisting chronic conditions in the same patient—is linked to more frequent and more severe COPD exacerbations, complicating treatment and worsening outcomes.
- Why it matters: Coexisting cardiovascular or metabolic diseases create major management challenges in COPD by increasing exacerbation burden and making treatment decisions harder.
- What they did: This review synthesizes evidence on multimorbidity prevalence and clinical significance in COPD, emphasizing shared risk factors and mechanisms such as systemic inflammation and oxidative stress, and discusses management strategies and biomarkers.
- The result: The findings support a multidisciplinary, personalised approach and highlight biomarkers as a potential tool for managing COPD alongside coexisting conditions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.